Published in Int J Sports Med on August 01, 1986
Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells. Front Physiol (2013) 0.97
Insulin-dependent diabetes mellitus and marathon running. Br J Sports Med (1987) 0.84
Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy? PLoS One (2010) 0.79
Muscle oxygen supply impairment during exercise in poorly controlled type 1 diabetes. Med Sci Sports Exerc (2015) 0.77
Statin Therapy Alters Lipid Storage in Diabetic Skeletal Muscle. Front Endocrinol (Lausanne) (2016) 0.75
Competitive sport and the insulin-dependent diabetic patient. Postgrad Med J (1990) 0.75
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. Epidemiol Rev (1984) 5.98
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med (1996) 4.44
Summary of an international workshop on typhoid fever. Rev Infect Dis (1986) 4.21
Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis (1999) 3.38
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli. J Infect Dis (1983) 2.71
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis (1997) 2.55
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care (2001) 2.37
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect Immun (1992) 2.23
Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol (1998) 2.22
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. Eur J Endocrinol (1997) 2.10
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis (1995) 2.10
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03
Vesicular stomatitis virus replication in human leukocyte cultures: enhancement by phytohemagglutinin. Science (1966) 2.03
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis (1992) 1.94
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis (1993) 1.93
Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy (1991) 1.90
Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care (2001) 1.88
High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg (1996) 1.86
Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. Lancet (1973) 1.79
The epidemiology of acquired immunodeficiency syndrome among heterosexuals. JAMA (1988) 1.78
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine (1992) 1.69
Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes? Diabet Med (2008) 1.67
Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol (2009) 1.65
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun (2000) 1.63
Lyme disease ecology in Wisconsin: distribution and host preferences of Ixodes dammini, and prevalence of antibody to Borrelia burgdorferi in small mammals. Am J Trop Med Hyg (1987) 1.59
New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae. Infect Immun (1996) 1.58
Acute medical problems in the Himalayas outside the setting of altitude sickness. High Alt Med Biol (2000) 1.56
Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. Am J Trop Med Hyg (1986) 1.55
Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. Lancet (1973) 1.52
Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia. Crit Care Med (1999) 1.51
Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur J Appl Physiol Occup Physiol (1997) 1.49
Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health (2008) 1.49
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. Am J Trop Med Hyg (1997) 1.48
Isodisomy of chromosome 6 in a newborn with methylmalonic acidemia and agenesis of pancreatic beta cells causing diabetes mellitus. J Clin Invest (1994) 1.46
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J Infect Dis (1977) 1.44
Specific role of each human leukocyte type in viral infections. 3. 17D yellow fever virus replication and interferon production in homogeneous leukocyte cultures treated with phytohemagglutinin. J Immunol (1969) 1.44
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect Immun (1997) 1.43
Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications. Eur J Pediatr (1996) 1.39
Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro. Diabete Metab (1993) 1.39
Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg (1992) 1.38
Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro. J Virol (1967) 1.37
Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro. J Virol (1968) 1.36
Human immunoglobulin M antibody in the sero-diagnosis of Japanese encephalitis virus infections. Am J Epidemiol (1973) 1.36
The active E rosette test: correlation with delayed cutaneous hypersensitivity. J Immunol (1976) 1.36
Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. Am J Trop Med Hyg (1976) 1.35
Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis (1974) 1.34
Secretory and serum IgA in children with protein-calorie malnutrition. Pediatrics (1975) 1.31
Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. Diabet Med (1998) 1.29
Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg (1993) 1.27
Postexercise proteinuria in humans. Facts and mechanisms. JAMA (1985) 1.26
Does glutamine have a role in reducing infections in athletes? Eur J Appl Physiol Occup Physiol (1996) 1.25
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine (1994) 1.24
Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun (2001) 1.23
Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections. Am J Epidemiol (1973) 1.22
Classification of HTLV-III/LAV-related diseases. J Infect Dis (1985) 1.22
What level of HbA1c can be achieved in young diabetic patients beyond the honeymoon period? Diabetes Care (1993) 1.22
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J Clin Invest (1992) 1.21
Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus. Am J Epidemiol (1973) 1.18
Vaccine adjuvants. Rev Infect Dis (1980) 1.17
Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia (2001) 1.16
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin Immunol (2000) 1.14
EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) (1979) 1.13
The active E-rosette test: a sensitive in vitro correlate for human delayed-type hypersensitivity. J Immunol (1977) 1.12
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J Infect Dis (2000) 1.12
Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine (1999) 1.12
Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg (2001) 1.11
Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant (2003) 1.10
CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J Immunol (1993) 1.09
Association of asymmetric crying facies, malformation of the ear and pulmonary agenesis. Acta Paediatr Belg (1976) 1.07
Hb Belliard [alpha 56(E5)Lys----Asn] a new fast-moving alpha chain variant found in a subject of Spanish origin. Hemoglobin (1989) 1.06
Erythrocyte and plasma antioxidant activity and subclinical complications in young diabetic patients. Diabetes Care (1996) 1.06
Determination of regional pulmonary parenchymal strain during normal respiration using spin inversion tagged magnetization MRI. J Magn Reson Imaging (2001) 1.06
Congenital absence of insulin cells in a neonate with diabetes mellitus and mutase-deficient methylmalonic acidaemia. Diabetologia (1993) 1.05
Vitamin A supplementation but not deworming improves growth of malnourished preschool children in eastern Zaire. J Nutr (1998) 1.04
Acute diarrheal infections in infants I. Bacterial and viral causes. Hosp Pract (1980) 1.03
Enhancement of replication of vesicular stomatitis virus in human lymphocyte cultures treated with heterologous anti-lymphocyte serum. Lancet (1968) 1.02
Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care (1997) 1.02
Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis (2001) 1.00
Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int Immunol (1991) 1.00
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infect Immun (1997) 0.99
Study of the coefficient of glucose assimilation during muscular exercise in diabetic adolescents deprived of insulin. Diabete Metab (1977) 0.99
HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia (1986) 0.98
The epidemiology of antibody to hepatitis C in Egypt. J Infect Dis (1993) 0.98
Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am J Trop Med Hyg (1991) 0.98
Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J Infect Dis (1979) 0.98
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O. Trans R Soc Trop Med Hyg (1995) 0.97
Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr Diabetes (2009) 0.97
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine (2001) 0.96
Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol (2009) 0.96
Biochemical changes in a 100 km run: free amino acids, urea, and creatinine. Eur J Appl Physiol Occup Physiol (1979) 0.96